Key Benefits

• Check hormone and protein signals linked to sarcopenia, muscle strength, and mass.
• Spot early muscle loss risk via low IGF-1, reflecting weaker growth signals.
• Clarify fatigue, weakness, or low libido by detecting testosterone deficiency, especially in men.
• Guide nutrition and training by using albumin to flag inadequate protein intake or inflammation.
• Distinguish normal aging from treatable low testosterone using age-adjusted ranges and symptoms.
• Inform therapy choices, including resistance training, protein targets, or hormone specialist referral when warranted.
• Protect fertility by identifying low testosterone before considering therapies that suppress sperm.
• Track progress by rechecking levels, best interpreted with strength tests and body composition.

What are Sarcopenia biomarkers?

Sarcopenia biomarkers are blood signals that map the biology of age‑related muscle loss. They show how much muscle you have, how actively it’s being renewed, and whether your body is leaning toward building or breaking down. Some come directly from muscle and reflect quantity (creatinine) and local growth brakes or accelerators (myostatin, follistatin). Others capture whole‑body forces that shape muscle health—anabolic drivers that support repair and synthesis (IGF‑1, testosterone) and inflammatory cues that push tissue toward breakdown (C‑reactive protein, interleukin‑6, TNF‑α). Nutrient‑hormone supports reveal readiness of the muscle system (vitamin D). Pairing signals can sharpen the picture—comparing a muscle‑linked marker with one not tied to muscle (creatinine with cystatin C) helps estimate true muscle mass behind routine numbers. Together, these biomarkers translate invisible shifts in skeletal muscle biology into measurable data, enabling earlier recognition of sarcopenia, more tailored exercise and nutrition strategies, and objective tracking of change over time.

Why is blood testing for Sarcopenia important?

Sarcopenia blood biomarkers capture how your body builds, repairs, and preserves muscle across systems. Insulin-like growth factor 1 (IGF-1) signals anabolic drive, testosterone supports muscle fiber size and strength, and albumin reflects protein reserve and inflammation. Together they mirror the muscle–endocrine–immune network that influences mobility, glucose handling, bone health, and resilience with aging.Within age- and sex-specific reference ranges, IGF-1 that sits in the mid-to-upper range often aligns with better muscle protein synthesis. Testosterone in the sex-appropriate mid-range supports strength and recovery in men; women benefit from adequate physiologic androgen levels without exceeding normal. Albumin is most informative when solidly within the normal range; low-normal can hint at systemic inflammation or inadequate protein status, while “high” albumin usually reflects dehydration rather than extra muscle.When these values are low, physiology tilts catabolic. Low IGF-1 or testosterone signals reduced synthesis and accelerated loss of lean mass—felt as declining strength, slower recovery, fatigue, and, over time, poorer balance and bone density. Men may notice diminished morning erections and vigor; women may experience low energy and reduced exercise tolerance; older adults face higher fall and frailty risk. Low albumin often marks inflammation or malnutrition, with edema and slower wound healing. Unusually high IGF-1 or testosterone can indicate endocrine disorders and may bring acne, fluid retention, or metabolic strain; elevated albumin typically indicates underhydration. Teens naturally have higher IGF-1 during growth, and pregnancy lowers albumin via hemodilution, so interpretation must be contextual.Big picture: these markers connect muscle to metabolism, hormones, and immunity. Monitoring them alongside strength and gait measures helps quantify sarcopenia risk, anticipate disability, diabetes and cardiovascular complications, and understand long-term health trajectory.

What insights will I get?

Sarcopenia blood testing provides insight into the body’s ability to maintain muscle mass, strength, and function—key elements for overall vitality, mobility, and resilience as we age. Muscle health is deeply connected to energy metabolism, cardiovascular stability, cognitive performance, and immune defense. At Superpower, we assess three core biomarkers for sarcopenia risk: IGF-1, Testosterone, and Albumin.IGF-1 (Insulin-like Growth Factor 1) is a hormone that signals muscle growth and repair, reflecting the body’s anabolic (building) capacity. Testosterone, present in all genders but at higher levels in males, also drives muscle protein synthesis and supports muscle maintenance. Albumin, a major blood protein, indicates overall nutritional status and the body’s ability to build and repair tissues, including muscle.Healthy levels of IGF-1 and testosterone support stable muscle mass and function, helping to prevent the gradual loss of muscle (sarcopenia) that can compromise mobility and independence. Albumin acts as a marker of systemic stability; low levels may signal chronic illness, inflammation, or malnutrition, all of which can accelerate muscle loss. Together, these biomarkers provide a window into the body’s capacity to preserve muscle and adapt to physical demands.Interpretation of these results depends on factors such as age, sex, acute or chronic illness, medication use (like steroids or hormone therapy), and laboratory assay differences. For example, normal ranges shift with age and between sexes, and temporary changes can occur during illness or recovery.